Trials / Completed
CompletedNCT00000356
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
Pharmacokinetics of LAAM in Methadone Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the pharmacokinetics of L-alpha-acetylmethadol (LAAM) in adults transferred from methadone maintenance treatment for opiate dependence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LAAM |
Timeline
- Start date
- 1991-06-01
- Primary completion
- 1992-08-01
- Completion
- 1992-10-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000356. Inclusion in this directory is not an endorsement.